← Back to Search

Procedure

Reconstruction Flaps for Nasal Surgical Wounds

N/A
Waitlist Available
Led By Murad Alam, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All patients >18 years
Defect located on the nasal tip, infratip, or supratip of the nose
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 6-16 weeks
Awards & highlights

Study Summary

This trial is designed to compare the outcomes of two different types of surgery for repairing nasal tip wounds.

Who is the study for?
This trial is for adults over 18 with a nasal tip wound no larger than 15mm, who can understand and sign consent. It's not for those under 18, current smokers, people with infections or conditions that affect healing, or if their nose shape makes certain repairs less likely to work.Check my eligibility
What is being tested?
The study compares two types of nasal reconstruction techniques: nasalis sling flaps versus lobed transposition flaps. Participants will be randomly assigned to one of the methods and will complete questionnaires to assess aesthetic and functional outcomes.See study design
What are the potential side effects?
While specific side effects are not listed, typical risks may include discomfort at the surgery site, infection risk post-surgery, possible dissatisfaction with cosmetic results, and potential impact on nasal function.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.
Select...
My nasal defect is on the tip or close to the tip of my nose.
Select...
My wound is 15mm long or shorter.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 6-16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 6-16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Nasal Appearance and Function Evaluation Questionnaire (NAFEQ) Scale
Nasal Obstruction Symptom Evaluation (NOSE) Instrument
Surgical Outcome Scale
+1 more

Trial Design

2Treatment groups
Active Control
Group I: Nasalis Sling FlapActive Control1 Intervention
Group II: Lobed transposition flapActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,579 Previous Clinical Trials
916,753 Total Patients Enrolled
1 Trials studying Surgical Wound
285 Patients Enrolled for Surgical Wound
Murad Alam, MDPrincipal InvestigatorNorthwestern University
69 Previous Clinical Trials
2,548 Total Patients Enrolled

Media Library

Lobed Transposition Flap (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04729231 — N/A
Surgical Wound Research Study Groups: Nasalis Sling Flap, Lobed transposition flap
Surgical Wound Clinical Trial 2023: Lobed Transposition Flap Highlights & Side Effects. Trial Name: NCT04729231 — N/A
Lobed Transposition Flap (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04729231 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment available for this trial at the present time?

"The latest information from clinicaltrials.gov presents that this medical experiment is not actively recruiting participants. Initially posted on January 1st 2023 with the last edit being March 2nd 2022, no new applicants are desired at this moment in time; however 85 others trials have open enrolment for patients currently."

Answered by AI
~21 spots leftby Jan 2025